The global medical injection molding machine market was valued at USD 2.10 billion in 2024 and is projected to reach USD 3.16 billion by 2032, with a CAGR of 5.24%. This growth is driven by the demand for higher precision and efficiency in molding, particularly for minimally invasive devices and single-use instruments.

In the U.S., the medical injection molding machine market is set to grow from USD 0.28 billion in 2024 to USD 0.41 billion by 2032, with a CAGR of 4.80%. Factors such as the rise in minimally invasive surgical procedures and the need for patient-specific medical parts are driving this growth.

Asia-Pacific leads the global medical injection molding market, with 38% market share in 2024, driven by the growth of pharmaceutical and device manufacturing hubs in countries like China, India, and Japan. North America, on the other hand, benefits from its mature healthcare infrastructure and demand for high-quality medical devices.

Electric machines dominated the medical injection molding market in 2024, capturing 48% of the market share, due to their ability to produce micro parts with high accuracy and energy efficiency. The hot runner system segment held the largest share, accounting for 58% in 2024, due to its efficiency in shortening cycle times and reducing plastic waste.

Plastics continued to dominate the medical injection molding market by material type in 2024, representing around 86% of the total market share. This is attributed to the growing use of synthetic polymer-based products in single-use and less-invasive medical devices, thanks to their functionality and compatibility with sterilization processes.

Overall, the medical injection molding machine market is expected to see significant growth in the coming years, driven by advancements in technology, the demand for precision medical devices, and the focus on sustainability and energy conservation.

Read more at GlobeNewswire: Medical Injection Molding Machine Market to Reach USD 3.16